Pharmacological aspects of metabolic processes in the pulmonary microcirculation.
D000806:Angiotensin-Converting Enzyme Inhibitors; D000818:Animals; D001679:Biogenic Amines / Q000502:physiology; D004727:Endothelium / Q000502:physiology; D006801:Humans; D007700:Kinetics; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D008833:Microcirculation / Q000187:drug effects; D009569:Nitric Oxide; D010455:Peptides / Q000502:physiology; D011453:Prostaglandins / Q000502:physiology; D011652:Pulmonary Circulation / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D001679:Biogenic Amines; D010455:Peptides; D011453:Prostaglandins; D014665:Vasodilator Agents; D009569:Nitric Oxide